Skip to main content
B

Bal Pharma Ltd. — Investor Relations & Filings

Ticker · BALPHARMA ISIN · INE083D01012 LEI · 254900F3KMK38GUDIW74 BSE.NS Manufacturing
Filings indexed 557 across all filing types
Latest filing 2023-05-29 Regulatory Filings
Country IN India
Listing BSE.NS BALPHARMA

About Bal Pharma Ltd.

https://www.balpharma.com/

Bal Pharma Ltd. specializes in the development, manufacture, and marketing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Formulations. The organization operates manufacturing facilities compliant with international quality standards, including WHO-GMP certifications. Its product portfolio encompasses a wide range of therapeutic segments, including diabetology, cardiology, gastroenterology, oncology, and pain management. Notable APIs in its catalog include Gliclazide, Ebastine, and Benzydamine. The company maintains an integrated business model, supporting operations from research and development to large-scale production. Bal Pharma serves a global clientele, exporting its products to numerous international markets across multiple continents, while focusing on the delivery of high-quality medicinal products and specialized formulations.

Recent filings

Filing Released Lang Actions
Related Party Transactions
Regulatory Filings
2023-05-29 English
Financial Result Updates
Regulatory Filings
2023-05-29 English
Dividend
Regulatory Filings
2023-05-29 English
Updates
Regulatory Filings
2023-05-26 English
Annual Secretarial Compliance Report
Regulatory Filings
2023-05-26 English
Board Meeting — BAL PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period e…
Regulatory Filings
2023-05-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.